Clinical trials are serious business, but that doesn't mean the news can't be exciting! We're proud to announce that Mediforum is the first to receive official approval for conducting phase 3 clinical trials in Korea. It's a medical milestone – and we cou
Aducanumab, the latest drug approved by the FDA for the treatment of Alzheimer'sis estimated to cost $56,000 annually. According to the New York Times, "There’s little evidence that the drug, Aduhelm, slows the progression of dementia, but the Food and Dr
Brain One is a naturally derived supplement made from a combination of extracts to improve memory %26 concentration. Combining the natural compounds with four-year-aged Korean ginseng boosts the immune system, enhances platelet count, and increases blood
